Mayne Pharma reported AUD267.98M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 4.84B 1.48B Aug/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Cochlear AUD 7.9B 9.15B Aug/2026
CSL USD 60.19B 4.3B Aug/2026
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Medical Developments International AUD 37.11M 25.41M Aug/2026
Nanosonics AUD 963.21M 241.07M Aug/2026
Polynovo AUD 849.74M 24.18M Dec/2025
Ramsay Health Care AUD 10.02B 2.09B Aug/2026
ResMed USD 47.56B 4.96B Mar/2026
Sigma Healthcare AUD 2.9B 1.78B Jul/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025